Take a look at Ocata Therapeutics, OCAT, a company with incredible clinical esults to date, with more to come, who clearly seem on the clinical path to stopping/preventing blindness from macular degeneration in the aging and stargardts disease in younger individuals.
Stem cells and regenerative medicine is where the practice of medicine is going and OCATA appears poised to possibly have a multi billion dollar revenue solution to treating eye diseases worldwide. Clinical data on humans to date, is just incredibly positive.
News 
Market Data 
Discover 
